Fresenius forms agreement with Humana for members with kidney disease
Click Here to Manage Email Alerts
Following an announcement that its dialysis facilities will be joining a data exchange network to improve patient care coordination, Fresenius Medical Care North America has expanded its partnership with Humana to further these efforts.
According to a press release, the agreement that resulted from this expanded partnership was designed for eligible Humana Medicare Advantage and commercial members with chronic kidney disease or end-stage kidney disease.
“This agreement represents an evolution of our work with Humana and leverages our over 10 years of industry leadership in value-based care,” Bill Valle, CEO of FMCNA, said in the release. “Our scale, integrated nephrology network, and standardized clinical interventions and protocols uniquely position us to predictably and consistently improve health outcomes and reduce overall costs.”
Elaborating on the agreement, the release noted the three primary components that will be addressed include the following: expanding availability of care coordination services; placing additional focus on transitional care units; and providing value-based care.
“We welcome this opportunity to offer more coordinated, holistic care to Humana’s members, with a keen focus on education, comorbidity management, early detection, and treatment options, including home dialysis,” Valle added. “This approach also helps eliminate barriers to keep renal disease treatment uninterrupted for at-risk populations.”
William Shrank, MD, MSHS, chief medical officer for Humana, also commented on the expanded partnership.
“As Humana continues to prioritize innovative solutions in response to today’s greatest health care challenges, we’re pleased to collaborate with Fresenius Medical Care North America, an organization of broad capability with which we can execute an important initiative of this scale,” he said. “In the evolution of renal disease care, we are confident that the best way to improve health outcomes and the patient experience is personalized coordination that meets the needs of each individual.”
Shrank noted this type of care is especially important during health pandemics, like that for COVID-19.
The agreement is set to go into effect on Jan. 1, 2021.
Read more about
Click Here to Manage Email Alerts